Friday, 14 Dec 2018
Advertisement

SCI-TECH | Genetic test helps predict disease recurrence in myelodysplastic syndrome

CHICAGO, ILLINOIS — A DNA-based analysis of blood cells soon after a stem cell transplant can predict the likelihood of disease recurrence in patients with myelodysplastic syndrome (MDS), according to a study at Washington University School of Medicine in St. Louis. In the study, published Thursday in the New England Journal of Medicine, the researchers […]

Continue Reading